| Product Code: ETC8565199 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Narcotic Drugs Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Narcotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Narcotic Drugs Market - Industry Life Cycle |
3.4 New Zealand Narcotic Drugs Market - Porter's Five Forces |
3.5 New Zealand Narcotic Drugs Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 New Zealand Narcotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 New Zealand Narcotic Drugs Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.8 New Zealand Narcotic Drugs Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.9 New Zealand Narcotic Drugs Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 New Zealand Narcotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases and pain conditions requiring narcotic drugs |
4.2.2 Growing awareness and acceptance of opioid therapy for pain management |
4.2.3 Government initiatives to improve access to healthcare services and medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and controls on narcotic drugs to prevent abuse and misuse |
4.3.2 Rising concerns about opioid addiction and associated risks |
4.3.3 Limited availability of specialized healthcare professionals for prescribing and monitoring narcotic drug use |
5 New Zealand Narcotic Drugs Market Trends |
6 New Zealand Narcotic Drugs Market, By Types |
6.1 New Zealand Narcotic Drugs Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Narcotic Drugs Market Revenues & Volume, By Source, 2021- 2031F |
6.1.3 New Zealand Narcotic Drugs Market Revenues & Volume, By Natural, 2021- 2031F |
6.1.4 New Zealand Narcotic Drugs Market Revenues & Volume, By Semi-synthetic, 2021- 2031F |
6.1.5 New Zealand Narcotic Drugs Market Revenues & Volume, By Synthetic, 2021- 2031F |
6.2 New Zealand Narcotic Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Narcotic Drugs Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.2.3 New Zealand Narcotic Drugs Market Revenues & Volume, By Cough, 2021- 2031F |
6.2.4 New Zealand Narcotic Drugs Market Revenues & Volume, By Diarrhea, 2021- 2031F |
6.2.5 New Zealand Narcotic Drugs Market Revenues & Volume, By Dysentery, 2021- 2031F |
6.2.6 New Zealand Narcotic Drugs Market Revenues & Volume, By Asthma, 2021- 2031F |
6.2.7 New Zealand Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 New Zealand Narcotic Drugs Market, By Drug |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Narcotic Drugs Market Revenues & Volume, By Opium, 2021- 2031F |
6.3.3 New Zealand Narcotic Drugs Market Revenues & Volume, By Heroin, 2021- 2031F |
6.3.4 New Zealand Narcotic Drugs Market Revenues & Volume, By Codeine, 2021- 2031F |
6.3.5 New Zealand Narcotic Drugs Market Revenues & Volume, By Oxycodone, 2021- 2031F |
6.3.6 New Zealand Narcotic Drugs Market Revenues & Volume, By Hydrocodone, 2021- 2031F |
6.3.7 New Zealand Narcotic Drugs Market Revenues & Volume, By Tramadol, 2021- 2031F |
6.3.8 New Zealand Narcotic Drugs Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.3.9 New Zealand Narcotic Drugs Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.3.10 New Zealand Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 New Zealand Narcotic Drugs Market, By Administration |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Narcotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 New Zealand Narcotic Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 New Zealand Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 New Zealand Narcotic Drugs Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Narcotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 New Zealand Narcotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 New Zealand Narcotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 New Zealand Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 New Zealand Narcotic Drugs Market Import-Export Trade Statistics |
7.1 New Zealand Narcotic Drugs Market Export to Major Countries |
7.2 New Zealand Narcotic Drugs Market Imports from Major Countries |
8 New Zealand Narcotic Drugs Market Key Performance Indicators |
8.1 Number of prescriptions for narcotic drugs |
8.2 Patient satisfaction with pain management using narcotic drugs |
8.3 Adherence to prescribing guidelines and regulations |
8.4 Number of healthcare facilities offering pain management services |
8.5 Rate of adverse events or complications associated with narcotic drug use |
9 New Zealand Narcotic Drugs Market - Opportunity Assessment |
9.1 New Zealand Narcotic Drugs Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 New Zealand Narcotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 New Zealand Narcotic Drugs Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.4 New Zealand Narcotic Drugs Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.5 New Zealand Narcotic Drugs Market Opportunity Assessment, By End users, 2021 & 2031F |
10 New Zealand Narcotic Drugs Market - Competitive Landscape |
10.1 New Zealand Narcotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Narcotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here